Tom Reuvekamp

11PUBLICATIONS
48CO-AUTHORS
Stochastic analysis and modellingMedical mycologyTumour immunologyHaematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 14, 2026
Prognostic value of measuring LSC frequency in AML: a systematic review and meta-analysis.

|Jun 08, 2026
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|Jul 14, 2025
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy.

Jort J van der Schans, Paresh Vishwasrao, Renée Poels

|Dec 20, 2024
Computational assessment of measurable residual disease in acute myeloid leukemia using mixture models.

Tim R Mocking, Angèle Kelder, Tom Reuvekamp

|Aug 23, 2024
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cells.

Tom Reuvekamp, Luca L G Janssen, Lok Lam Ngai

Pageof 2

Frequent Collaborators

6 joint publications

Costa Bachas

6 joint publications

Jacqueline Cloos

5 joint publications

David C de Leeuw

5 joint publications

Lukas H Haaksma